These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 35872504)
1. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. Kapoor-Narula U; Lenka N Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504 [TBL] [Abstract][Full Text] [Related]
2. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C Cells; 2020 Aug; 9(8):. PubMed ID: 32823711 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of the cancer stem cell niche and therapeutic strategies. Ju F; Atyah MM; Horstmann N; Gul S; Vago R; Bruns CJ; Zhao Y; Dong QZ; Ren N Stem Cell Res Ther; 2022 Jun; 13(1):233. PubMed ID: 35659296 [TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells (CSCs) in cancer progression and therapy. Najafi M; Farhood B; Mortezaee K J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375 [TBL] [Abstract][Full Text] [Related]
5. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related]
6. The strategies to cure cancer patients by eradicating cancer stem-like cells. Mai Y; Su J; Yang C; Xia C; Fu L Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. Eun K; Ham SW; Kim H BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397 [TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes. Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138 [TBL] [Abstract][Full Text] [Related]
9. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche. Kilmister EJ; Tan ST J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363 [TBL] [Abstract][Full Text] [Related]
10. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. Li YR; Fang Y; Lyu Z; Zhu Y; Yang L J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157 [TBL] [Abstract][Full Text] [Related]
11. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Yan Y; Zuo X; Wei D Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295 [TBL] [Abstract][Full Text] [Related]
13. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677 [TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U Front Immunol; 2020; 11():1280. PubMed ID: 32849491 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells and their niche in the progression of squamous cell carcinoma. Oshimori N Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236 [TBL] [Abstract][Full Text] [Related]
16. Cancer cells stemness: A doorstep to targeted therapy. Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002 [TBL] [Abstract][Full Text] [Related]
17. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells. Zhang Z; Deng Q; Xiao C; Li Z; Yang X Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133 [TBL] [Abstract][Full Text] [Related]
18. An emerging role for cellular crosstalk in the cancer stem cell niche. Oshimori N; Guo Y; Taniguchi S J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866 [TBL] [Abstract][Full Text] [Related]
19. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127 [TBL] [Abstract][Full Text] [Related]